• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于个性化老年2型糖尿病管理的人体数字孪生模型

Human Digital Twin for Personalized Elderly Type 2 Diabetes Management.

作者信息

Thamotharan Padmapritha, Srinivasan Seshadhri, Kesavadev Jothydev, Krishnan Gopika, Mohan Viswanathan, Seshadhri Subathra, Bekiroglu Korkut, Toffanin Chiara

机构信息

Kalasalingam Academy of Research and Education, Srivilliputhur 626126, Tamil Nadu, India.

TVS-Sensing Solutions Pvt Ltd., Madurai 625122, Tamil Nadu, India.

出版信息

J Clin Med. 2023 Mar 7;12(6):2094. doi: 10.3390/jcm12062094.

DOI:10.3390/jcm12062094
PMID:36983097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10056736/
Abstract

Managing Elderly type 2 diabetes (E-T2D) is challenging due to geriatric conditions (e.g., co-morbidity, multiple drug intake, etc.), and personalization becomes paramount for precision medicine. This paper presents a human digital twin (HDT) framework to manage E-T2D that exploits various patient-specific data and builds a suite of models exploiting the data for prediction and management to personalize diabetes treatment in E-T2D patients. These models include mathematical and deep-learning ones that capture different patient aspects. Consequently, the HDT virtualizes the patient from different viewpoints using an HDT that mimics the patient and has interfaces to update the virtual models simultaneously from measurements. Using these models the HDT obtains deeper insights about the patient. Further, an adaptive patient model fusing this information and a learning-based model predictive control (LB-MPC) algorithm are proposed. The geriatric conditions are captured as model parameters and constraints while solving the LB-MPC to personalize the insulin infusion for E-T2D management. The HDT is deployed on and illustrated with 15 patients using clinical trials and simulations. Our results show that HDT helps improve the time-in-range from 3-75% to 86-97% and reduces insulin infusion by 14-29%.

摘要

由于老年疾病(如合并症、多种药物摄入等),管理老年2型糖尿病(E-T2D)具有挑战性,因此个性化对于精准医学至关重要。本文提出了一种用于管理E-T2D的人类数字孪生(HDT)框架,该框架利用各种患者特定数据,并构建了一套利用这些数据进行预测和管理的模型,以实现E-T2D患者糖尿病治疗的个性化。这些模型包括捕获患者不同方面的数学模型和深度学习模型。因此,HDT从不同视角对患者进行虚拟化,使用一个模仿患者的HDT,并具有从测量中同时更新虚拟模型的接口。利用这些模型,HDT对患者有了更深入的了解。此外,还提出了一种融合此信息的自适应患者模型和基于学习的模型预测控制(LB-MPC)算法。在求解LB-MPC以实现E-T2D管理的胰岛素输注个性化时,将老年疾病作为模型参数和约束条件。通过临床试验和模拟,HDT在15名患者身上进行了部署和展示。我们的结果表明,HDT有助于将血糖在目标范围内的时间从3 - 75%提高到86 - 97%,并将胰岛素输注量减少14 - 29%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/734638b0a8df/jcm-12-02094-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/b7347bbd28c5/jcm-12-02094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/14285755e65c/jcm-12-02094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/696cfc54aebf/jcm-12-02094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/01b587d1a41c/jcm-12-02094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/b4948d49bf71/jcm-12-02094-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/6b8e57ec5ee7/jcm-12-02094-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/30b5f22aaa5d/jcm-12-02094-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/15a9e6c0caa6/jcm-12-02094-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/24f1f5185637/jcm-12-02094-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/9714256912ca/jcm-12-02094-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/0aa4fa1c73ad/jcm-12-02094-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/ce543dd6fcb7/jcm-12-02094-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/9f71ab5d942c/jcm-12-02094-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/421dc474449d/jcm-12-02094-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/9d4c0360eaa3/jcm-12-02094-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/61be769ea9a0/jcm-12-02094-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/5a6098adfa4c/jcm-12-02094-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/7625128b2525/jcm-12-02094-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/dde92d4e40b1/jcm-12-02094-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/150844329489/jcm-12-02094-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/6b41e5843418/jcm-12-02094-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/dc59e1b11f91/jcm-12-02094-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/e5bf6fd13ab9/jcm-12-02094-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/d6d0b4bf0687/jcm-12-02094-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/3fcd82909c4f/jcm-12-02094-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/4c3f1c9299a9/jcm-12-02094-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/aea421979792/jcm-12-02094-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/8cb36fdc9681/jcm-12-02094-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/734638b0a8df/jcm-12-02094-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/b7347bbd28c5/jcm-12-02094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/14285755e65c/jcm-12-02094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/696cfc54aebf/jcm-12-02094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/01b587d1a41c/jcm-12-02094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/b4948d49bf71/jcm-12-02094-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/6b8e57ec5ee7/jcm-12-02094-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/30b5f22aaa5d/jcm-12-02094-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/15a9e6c0caa6/jcm-12-02094-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/24f1f5185637/jcm-12-02094-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/9714256912ca/jcm-12-02094-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/0aa4fa1c73ad/jcm-12-02094-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/ce543dd6fcb7/jcm-12-02094-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/9f71ab5d942c/jcm-12-02094-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/421dc474449d/jcm-12-02094-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/9d4c0360eaa3/jcm-12-02094-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/61be769ea9a0/jcm-12-02094-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/5a6098adfa4c/jcm-12-02094-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/7625128b2525/jcm-12-02094-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/dde92d4e40b1/jcm-12-02094-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/150844329489/jcm-12-02094-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/6b41e5843418/jcm-12-02094-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/dc59e1b11f91/jcm-12-02094-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/e5bf6fd13ab9/jcm-12-02094-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/d6d0b4bf0687/jcm-12-02094-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/3fcd82909c4f/jcm-12-02094-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/4c3f1c9299a9/jcm-12-02094-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/aea421979792/jcm-12-02094-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/8cb36fdc9681/jcm-12-02094-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7694/10056736/734638b0a8df/jcm-12-02094-g029.jpg

相似文献

1
Human Digital Twin for Personalized Elderly Type 2 Diabetes Management.用于个性化老年2型糖尿病管理的人体数字孪生模型
J Clin Med. 2023 Mar 7;12(6):2094. doi: 10.3390/jcm12062094.
2
ACT-R based human digital twin to enhance operators' performance in process industries.基于ACT-R的人类数字孪生体,以提升流程工业中操作员的绩效。
Front Hum Neurosci. 2023 Feb 8;17:1038060. doi: 10.3389/fnhum.2023.1038060. eCollection 2023.
3
A framework towards digital twins for type 2 diabetes.2型糖尿病数字孪生体的框架
Front Digit Health. 2024 Jan 26;6:1336050. doi: 10.3389/fdgth.2024.1336050. eCollection 2024.
4
Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems.在多变量人工胰腺系统的自适应模型预测控制中融入先验信息。
J Diabetes Sci Technol. 2022 Jan;16(1):19-28. doi: 10.1177/19322968211059149. Epub 2021 Dec 3.
5
Predictive digital twin for optimizing patient-specific radiotherapy regimens under uncertainty in high-grade gliomas.用于在高级别胶质瘤不确定性情况下优化患者特异性放疗方案的预测性数字孪生模型。
Front Artif Intell. 2023 Oct 11;6:1222612. doi: 10.3389/frai.2023.1222612. eCollection 2023.
6
Health digital twins as tools for precision medicine: Considerations for computation, implementation, and regulation.作为精准医学工具的健康数字孪生:计算、实施和监管方面的考量
NPJ Digit Med. 2022 Sep 22;5(1):150. doi: 10.1038/s41746-022-00694-7.
7
Digital Transformation in Personalized Medicine with Artificial Intelligence and the Internet of Medical Things.人工智能和医疗物联网在个性化医学中的数字化转型。
OMICS. 2022 Feb;26(2):77-81. doi: 10.1089/omi.2021.0037. Epub 2021 Apr 21.
8
Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program.数字工具用于整合个性化糖尿病管理的获益:PDM-ProValue 研究项目的结果。
J Diabetes Sci Technol. 2020 Mar;14(2):240-249. doi: 10.1177/1932296819867686. Epub 2019 Aug 5.
9
A Review and Qualitative Meta-Analysis of Digital Human Modeling and Cyber-Physical-Systems in Ergonomics 4.0.人机工程学4.0中数字人体建模与信息物理系统的综述及定性荟萃分析
IISE Trans Occup Ergon Hum Factors. 2021 Jul-Dec;9(3-4):111-123. Epub 2021 Aug 30.
10
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.基于数据驱动的血糖动力学建模与预测:机器学习在 1 型糖尿病中的应用。
Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26.

引用本文的文献

1
An effective PO-RSNN and FZCIS based diabetes prediction and stroke analysis in the metaverse environment.在元宇宙环境中基于有效PO-RSNN和FZCIS的糖尿病预测与中风分析
Sci Rep. 2025 Apr 4;15(1):11633. doi: 10.1038/s41598-025-96541-2.
2
Digital Twins for Clinical and Operational Decision-Making: Scoping Review.用于临床和运营决策的数字孪生:范围综述
J Med Internet Res. 2025 Jan 8;27:e55015. doi: 10.2196/55015.
3
Definitions and Characteristics of Patient Digital Twins Being Developed for Clinical Use: Scoping Review.用于临床应用的患者数字孪生体的定义和特征:范围综述。

本文引用的文献

1
Cardiovascular/Stroke Risk Stratification in Diabetic Foot Infection Patients Using Deep Learning-Based Artificial Intelligence: An Investigative Study.使用基于深度学习的人工智能对糖尿病足感染患者进行心血管/中风风险分层:一项调查研究。
J Clin Med. 2022 Nov 19;11(22):6844. doi: 10.3390/jcm11226844.
2
Digital Twins in Radiology.放射学中的数字孪生
J Clin Med. 2022 Nov 4;11(21):6553. doi: 10.3390/jcm11216553.
3
Macronutrient Recommendations for Remission and Prevention of Diabetes in Asian Indians Based on a Data-Driven Optimization Model: The ICMR-INDIAB National Study.
J Med Internet Res. 2024 Nov 13;26:e58504. doi: 10.2196/58504.
4
Evolution of digital twins in precision health applications: a scoping review study.精准健康应用中数字孪生的发展:一项范围综述研究。
Res Sq. 2024 Aug 7:rs.3.rs-4612942. doi: 10.21203/rs.3.rs-4612942/v1.
5
The effectiveness of digital twins in promoting precision health across the entire population: a systematic review.数字孪生技术在促进全民精准健康方面的有效性:一项系统综述。
NPJ Digit Med. 2024 Jun 3;7(1):145. doi: 10.1038/s41746-024-01146-0.
6
Personalized Diabetes Management with Digital Twins: A Patient-Centric Knowledge Graph Approach.基于数字孪生的个性化糖尿病管理:一种以患者为中心的知识图谱方法。
J Pers Med. 2024 Mar 28;14(4):359. doi: 10.3390/jpm14040359.
7
The potential of the Medical Digital Twin in diabetes management: a review.医学数字孪生在糖尿病管理中的潜力:综述
Front Med (Lausanne). 2023 Jul 20;10:1178912. doi: 10.3389/fmed.2023.1178912. eCollection 2023.
基于数据驱动优化模型的亚洲印度人糖尿病缓解和预防的宏量营养素建议:印度医学研究理事会-印度糖尿病(ICMR-INDIAB)全国性研究
Diabetes Care. 2022 Aug 18. doi: 10.2337/dc22-0627.
4
Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus.美敦力 780G 胰岛素输注系统优化 1 型糖尿病患者的血糖控制。
Nutr Metab Cardiovasc Dis. 2022 Jul;32(7):1719-1724. doi: 10.1016/j.numecd.2022.03.031. Epub 2022 Apr 13.
5
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations.2型糖尿病的个性化管理:近期进展与建议的最新情况
Diabetes Metab Syndr Obes. 2022 Feb 4;15:281-295. doi: 10.2147/DMSO.S331654. eCollection 2022.
6
Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems.在多变量人工胰腺系统的自适应模型预测控制中融入先验信息。
J Diabetes Sci Technol. 2022 Jan;16(1):19-28. doi: 10.1177/19322968211059149. Epub 2021 Dec 3.
7
Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.混合闭环系统对 1 型糖尿病患儿和青少年血糖和心理社会结局的影响:一项随机临床试验。
JAMA Pediatr. 2021 Dec 1;175(12):1227-1235. doi: 10.1001/jamapediatrics.2021.3965.
8
Diabetes Mellitus and Heart Failure.糖尿病与心力衰竭
J Clin Med. 2021 Aug 19;10(16):3682. doi: 10.3390/jcm10163682.
9
Type 2 diabetes mellitus in older adults: clinical considerations and management.老年人 2 型糖尿病:临床注意事项与管理。
Nat Rev Endocrinol. 2021 Sep;17(9):534-548. doi: 10.1038/s41574-021-00512-2. Epub 2021 Jun 25.
10
Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis.1型糖尿病患者体育锻炼期间闭环系统与标准治疗的血糖达标时间:一项系统评价和荟萃分析
J Clin Med. 2021 May 31;10(11):2445. doi: 10.3390/jcm10112445.